PAS
JAZZ icon

Point72 Asia (Singapore)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Point72 Asia (Singapore)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$18K Buy
+137
New +$16.4K ﹤0.01% 725
2025
Q2 		– Sell
-11
Closed -$1.37K – 1080
2025
Q1 		$1.37K Sell
11
-2,106
-99% -$275K ﹤0.01% 807
2024
Q4 		$261K Sell
2,117
-12,476
-85% -$1.47M 0.07% 210
2024
Q3 		$1.63M Buy
14,593
+4,627
+46% +$507K 0.31% 59
2024
Q2 		$1.06M Buy
+9,966
New +$1.1M 0.22% 91

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Point72 Asia (Singapore)'s JAZZ Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2025: 137 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #725 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in JAZZ as recently as Q1 2025.

Point72 Asia (Singapore) first reported a position in JAZZ in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.63M in Q3 2024. 502 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Point72 Asia (Singapore) held 137 shares of Jazz Pharmaceuticals worth $18K as of Q3 2025.
  • Jazz Pharmaceuticals was a new Point72 Asia (Singapore) position in Q3 2025.
  • Jazz Pharmaceuticals made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #725 holding.
  • Point72 Asia (Singapore) first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • Point72 Asia (Singapore)'s Jazz Pharmaceuticals position peaked at $1.63M in Q3 2024.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.